Dr Rebecca Abbott
Honorary (Fellow)
The Sir Peter MacCallum Department of Oncology
9 Scholarly works
0 Projects
HIGHLIGHTS
2025
Journal article
Chimeric antigen receptor T cell therapy in childhood leukaemia
DOI: 10.1136/archdischild-2024-3282632025
Journal article
CAR T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma
DOI: 10.1056/NEJMoa23097282023
Journal article
Endogenous H3.3K27M derived peptide restricted to HLA-A∗02:01 is insufficient for immune-targeting in diffuse midline glioma
DOI: 10.1016/j.omto.2023.08.0052023
Journal article
Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma
DOI: 10.1002/cti2.14402022
Journal article
To go or not to go? Biological logic gating engineered T cells
DOI: 10.1136/jitc-2021-0041852021
Journal article
Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastoma
DOI: 10.1002/cti2.12832021
Journal article
Corrigendum to: Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastoma (Clinical & Translational Immunology, (2021), 10, 5, 10.1002/cti2.1283)
DOI: 10.1002/cti2.1317
RECENT SCHOLARLY WORKS
2020
Journal article
Finding the keys to the CAR: Identifying novel target antigens for t cell redirection immunotherapies
DOI: 10.3390/ijms210205152020
Journal article
CD8 tumor-infiltrating lymphocytes within the primary tumor of patients with synchronous de novo metastatic colorectal carcinoma do not track with survival
DOI: 10.1002/cti2.1155